Clinical trial
Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose…
NCT00147953 · University of Cologne, Other · Completed
Key facts
| NCT number | NCT00147953 |
|---|---|
| Title | Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma |
| Official title | A Phase II Study of Rituximab Plus Low-Dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma |
| Lead sponsor | University of Cologne, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | Rituximab, Total nodal irradiation |
| Enrollment | 30 |
| Start date | Jun 1, 2004 |
| First posted | Sep 7, 2005 |
| Last update posted | Jan 27, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: